BIRMINGHAM, Ala.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that Dr. William P. Sheridan, Senior Vice President and Chief Medical Officer of BioCryst, plans to provide a corporate summary and updates regarding its clinical programs at the JMP Securities Healthcare Conference in New York City on Monday, September 27, 2010 at 2:30 p.m. Eastern Time.
